InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Mason Michael B, Vice-Président Senior. Director active across 2 companies, notably ELI LILLY & Co. Aggregated, 5 disclosures have been recorded. History available since 9 February 2022. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mason Michael B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
1,166 股0Common StockSEC:0001193125-26-004367:0
1,219 股0Common StockSEC:0001193125-25-328680:0
8,023 股@ US$345.1269.8% 占其流量Common StockSEC:0000059478-23-000055:0
6,690 股0Common StockSEC:0000059478-23-000035:0
2,612 股@ US$243.2717.8% 占其流量Common StockSEC:0000059478-22-000044:0
5 条申报中的 5 条
About Mason Michael B
Mason Michael B is Senior Vice President and has 5 filings in total. In the 5 recent filings we hold, the most common transaction nature is Attribution, with buy and sell amounts of EUR 0. The filings span 2022-02-11 to 2026-01-06 and concern ELI LILLY & Co, where he is EVP & Pres., Lilly Diabetes, and WW INTERNATIONAL, INC., where he is Director.
